A 6-month, Randomized, Open-label, Patient OutComes, Safety and Tolerability Study of Fingolimod (FTY720) 0.5 mg/Day vs. Comparator in Patients With Relapsing Forms of Multiple Sclerosis
Clinical trial NCT01216072 · COMPLETED
Trial details
- NCT number
- NCT01216072
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2012-08-01
- Enrollment
- 1053
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.